Scientists closer to outsmarting malaria parasites

Scientists closer to outsmarting malaria parasites
Credit: Pragyan Bezbaruah from Pexels

Researchers from The Australian National University (ANU) have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global fight against the disease.

The ANU team has characterized two proteins, known as PfMDR1 and PfCRT, that work together to transport drugs away from areas where they exert their killing effect and concentrate them in "safe zones" that ultimately render the treatments ineffective.

The findings could lead to new and longer-lasting treatments for malaria—a disease that killed an estimated 627,000 people worldwide in 2020.

According to Dr. Sarah Shafik from the ANU Research School of Biology certain anti-malarial treatments are only effective at eradicating the disease if the drugs are located inside the stomach of the parasite. Other treatments are most effective when located outside of the stomach.

"We knew that can be resistant to some drugs while simultaneously being susceptible to others, but we didn't know how this occurred," Dr. Shafik, a co-author of the study, said.

"Our work shows that PfMDR1 and PfCRT work together to alter the distribution of the drugs within the parasite, helping it to evade the killing effect of one . But in turn, this means that the parasite becomes more susceptible to another drug."

The discovery could lead scientists to develop new treatments or repurpose existing drugs to create new combination therapies that directly target the PfMDR1 and PfCRT proteins and prevent the parasites from outsmarting the drugs.

Although the disease can be successfully treated with drugs, malaria parasites are continually adapting and building resistance to current treatments, allowing them to evade death and stay one step ahead of scientists.

"This means that malaria treatments capable of treating patients today won't necessarily be effective in several years' time," Dr. Shafik said.

"The former gold standard drug, chloroquine, which was used to treat malaria for 20 years has failed. New treatments that are emerging only last a few years before the parasites start to develop resistance to these drugs.

"This is because the parasite is really good at mutating certain proteins to evade the killing effects of the drugs."

Besides their role in , the researchers say the two proteins are essential to the growth of the parasites. By rendering the proteins inactive using new and repurposed , scientists have a good chance at eradicating malaria.

"We are starting to develop a good understanding of how we could design an that doesn't become obsolete over time by using a combination of anti-malarial drugs that we already have in our arsenal, combined with other types of drugs that are used to treat HIV, for example," Dr. Shafik said.

"Our intention is to target the ability of PfMDR1 and PfCRT to control the movement of drugs inside the parasite, but also to inhibit the essential natural function of proteins which helps the parasite grow."

According to Dr. Shafik, the researchers' discovery could also help inform the development of new types of cancer treatments.

"There is a made by human that is similar to PfMDR1. We have developed a method to study these types of proteins," Dr. Shafik said.

"By characterizing the human version of PfMDR1 and figuring out which chemotherapy drugs it can pump out of cancer cells and how to stop the protein from doing this, we could be on the path to developing more successful cancer treatments."

The research is published in PLOS Biology.

More information: Sarah Heckmatt Shafik et al, Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT, PLOS Biology (2022). DOI: 10.1371/journal.pbio.3001616

Journal information: PLoS Biology
Citation: Scientists closer to outsmarting malaria parasites (2022, May 6) retrieved 29 March 2024 from https://medicalxpress.com/news/2022-05-scientists-closer-outsmarting-malaria-parasites.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Discovery could lead to new malaria treatments

79 shares

Feedback to editors